Comparison of ertapenem and ceftriaxone therapy for acute pyelonephritis and other complicated urinary tract infections in korean adults: A randomized, double-blind, multicenter trial

Dae Won Park, Kyong Ran Peck, Moon Hyun Chung, Jin Seo Lee, Yoon Soo Park, Hyo Youl Kim, Mi Suk Lee, Jung Yeon Kim, Joon Sup Yeom, Min Ja Kim

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

The efficacy and safety of ertapenem, 1 g once daily, were compared with that of ceftriaxone, 2 g once daily, for the treatment of adults with acute pyelonephritis (APN) and complicated urinary tract infections (cUTIs) in a prospective, multicenter, doubleblinded, randomized study. After ≥ 3 days of parenteral study therapy, patients could be switched to an oral agent. Of 271 patients who were initially stratified by APN (n = 210) or other cUTIs (n = 61), 66 (48.9%) in the ertapenem group and 71 (52.2%) in the ceftriaxone group were microbiologically evaluable. The mean duration of parenteral and total therapy, respectively, was 5.6 and 13.8 days for ertapenem and 5.8 and 13.8 days for ceftriaxone. The most common pathogen was Escherichia coli. At the primary efficacy endpoint 5-9 days after treatment, 58 (87.9%) patients in the ertapenem group and 63 (88.7%) in the ceftriaxone had a favorable microbiological response. When compared by stratum and severity, the outcomes in the two groups were equivalent. The frequency and severity of drug-related adverse events were generally similar in both treatment groups. The results indicate that ertapenem is highly effective and safe for the treatment of APN and cUTIs.

Original languageEnglish
Pages (from-to)476-483
Number of pages8
JournalJournal of Korean medical science
Volume27
Issue number5
DOIs
Publication statusPublished - 2012 May 1

Keywords

  • Ceftriaxone
  • Ertapenem
  • Pyelonephritis
  • Urinary tract infections

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Comparison of ertapenem and ceftriaxone therapy for acute pyelonephritis and other complicated urinary tract infections in korean adults: A randomized, double-blind, multicenter trial'. Together they form a unique fingerprint.

  • Cite this